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A 44-year-old woman presented at the Emergency
Department (ED) with cough and dyspnea started 2 days
prior. She was an active smoker, and she had a history of
neurofibromatosis type 1(NF) diagnosed about 20 years
prior by biopsy of the first nodule on the lower lip without
lung involvement. At presentation, the patient showed
sinus tachycardia (110 beats/min), tachypnea (respiratory
rate: 28 breaths/min), oxygen saturation 92 % on room air,
and body temperature 37.6 C.
Physical examination revealed several cafe´-au-lait
maculae and several nodules on her trunk.
Pulmonary examination showed reduced breath sounds
bilaterally associated with bilateral wheezes.
The 12-lead EKG demonstrated a normal sinus rhythm
at a rate of 99/min. Chest radiography revealed an image
suggestive for pulmonary hyperlucency, without acute
pulmonary consolidation and without bronchiectasis
(Fig. 1). Laboratory tests revealed an elevated WBC
(12.9 9 109/L) and fibrinogen level (479 mg/dL). Arterial
blood gas analysis showed hypoxia (PaO2 66.4 mmHg)
with normal pH and PaCO2 values.
Based on the initial presentation, normal EKG, hypoxia
and the presence of elevated inflammatory markers in the
laboratory tests, pulmonary infection was considered.
Thus, oxygen therapy (2L/min) by nasal probes and
antibiotics (Levofloxacin 750 mg, PO qd) were started. On
the second day, the hemodynamic and respiratory status did
not improve significantly. For this reason, we performed a
chest ultrasonography that showed two sub-pleural
hypoechogenic images, 0.5 and 0.7 cm in diameter, respec-
tively, in the lower field of left lung with rear-wall
reinforcement and a localized alveolar-interstitial
syndrome (Fig. 2).
On the basis of the result of chest ultrasonography, we
considered the clinical presentation as the lung involve-
ment of NF. So, we added to the current therapy, methyl-
prednisolone sodium succinate (60 mg daily, IV), and the
association of beclomethasone, ipratropium bromide, and
salbutamol (0.8, 0.25 and 5 mg, respectively, nebulized
bid). A significant improvement of respiratory status was
noted in a few hours. The ultrasonographic findings were
subsequently confirmed by a chest high resolution com-
puted tomography (HRCT) that showed diffuse small
rounded thin-walled lung cysts (1 cm), predominant in the
lower left lobe. Same lung cysts had a diameter of 3.3 cm
(Fig. 3). These abnormalities had a random distribution,
prevalent on the sub-pleural side with paraseptal emphy-
sema characteristics of neurofibromatosis. The chest HRCT
also showed a moderately thickened appearance of the
walls of some pyramids in basal bronchial branches, which
could be compatible with bronchiectasis. This apparent
discordance with the chest X-ray study can be explained by
the fact that HRCT demonstrates higher sensivity than
chest radiography in the detection of bronchiectasis.
Von Recklinghausen’s disease or neurofibromatosis type
1 is an autosomal dominant dysplasia of ectoderm and
mesoderm with a prevalence of 1 in 3,000. The typical
characteristic is the presence of neurofibromas. The
majority of patients have discrete benign neurofibromas
within the dermis. Nodular neurofibromas arise from
peripheral nerves at any site. Plexiform neurofibromas are
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usually congenital, and are present in 30 % of the patients
[1]. In about 2–16 % of the patients, nodular and plexiform
neurofibromas transform to malignant peripheral nerve
sheath tumors [1]. Optic nerve gliomas are seen in 15 % of
the patients [1]. About 95 % of the patients develop Lisch
nodules [1].
In NF, the chest and lungs can be affected in several
ways: cutaneous and subcutaneous neurofibromas on the
chest wall, kyphoscoliosis, ribbon deformity of the ribs,
and thoracic neoplasms [1]. An association of NF with
diffuse lung disease (DLD) has been described, but its true
prevalence and characteristics remain unclear and under-
estimated. The literature review reveals 64 adult patients
affected by NF-DLD; mean age 50 years, 69 % men.
Common symptoms include dyspnea (80 %) and cough
(32 %). Only 5 % of the patients complain of chest pain
and 11 % are asymptomatic [2]. The average age and
symptoms of ED presentation of our patient correlate with
previous papers. Regarding the types of lung lesions
detected by radiological examination, Zamora et al. [2]
report that chest radiography demonstrates bullous lung
disease in 73 % of the cases, almost always in the upper
lobes (93 %), and radiographic honeycombing sign in
13 % of the cases. Chest HRCT reveals emphysema
(25 %), cyst (25 %), ground-glass abnormality (37 %),
bullas (50 %) and reticular abnormalities (50 %). Ryu et al.
[3]. show a lack of evidence for an association between NF
and parenchymal lung disease. Particularly, interstitial lung
disease and bullas described in association with NF may
represent, at least in part, smoking-induced manifestation
[3]. In our case, chest radiography failed to show lung
parenchymal abnormalities consistent with NF-DLD,
whereas chest ultrasonography revealed the presence
of sub-pleural abnormalities compatible with bullae
confirmed by chest HRCT. To note, in our case, bullous
lesions were predominant in the lower lobes while cases
previously reported a prevalent upper lobes distribution.
Unfortunately, since our patient was an active smoker, she
could fall into the group with NF-DLD smoking-induced
manifestation.
The diagnostic modalities currently available to
demonstrate the lung involvement in NF are chest radiography
and chest HRCT. In recent years, the use of chest ultra-
sonography in the evaluation of patients with dyspnea in
the ED has been established, particularly demonstrating
high concordance with radiography [4] and providing
correct diagnoses of acute respiratory failure in 91 % of the
Fig. 3 Chest high resolution computer tomography showing diffuse
small rounded thin-walled lung cysts (arrows), predominantly in the
lower left lobe
Fig. 1 Chest radiography showing abnormalities suggestive of
pulmonary hyperinflation. Absence of acute parenchymal lung
consolidations
Fig. 2 Chest ultrasonography showing sub-pleural hypoechogenic
image (a), in the lower field of left lung with rear-wall reinforcement
and localized alveolar-interstitial syndrome (b)
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cases [5]. Our case suggests that chest ultrasonography
may have higher diagnostic accuracy than chest radiogra-
phy in the diagnosis of DLD even in patients with a rare
pathology like NF.
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